Developing breakthrough oncology drug candidates

Sprint Bioscience summarizes below the company’s upcoming meetings with potential partners and investors during the second half of 2026. The list is subject to change and is available on the company’s website. International partnering conferences: September 8–9, 2026 Nordic Life Science Days, Stockholm, Sweden https://nlsdays.com/ September 14–16, 2026 IPLS, International Partnering in Life Science Society Annual Conference, Stockholm, Sweden, https://ipls.online/events/, October 7–9, 2026, Bio Japan, Yokohama, Japan, https://jcd-expo.jp/en/, November 9–11 […]

Sprint Bioscience announced in a press release on July 23 that the company has entered into an agreement with Lilly TuneLab, a collaborative, AI-driven drug discovery platform created by Eli Lilly and Company (Lilly). By joining TuneLab, Sprint Bioscience intends to strengthen and accelerate the development of its portfolio through access to advanced models for…

Sprint Bioscience summarizes below the company's upcoming meetings with potential partners and investors in spring 2026. The list may be updated. Scientific conference: International partnering conferences: For investors: Current calendar and recorded presentations from the investor meetings can be viewed here: https://sprintbioscience.com/sv/kalender/https://sprintbioscience.com/sv/film/

On January 12-15, Sprint Bioscience will be present at J.P. Morgan Healthcare Week, the most important meeting place of the year for the global life science industry. Leading players gather here for a week filled with partnering, investor meetings and groundbreaking ideas. For Sprint Bioscience, this is a unique opportunity to present preclinical drug programs and make strategic contacts. In an interview...